Strategic Alliances for Medications Development to Treat Substance Use Disorder Program

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, otherwise known as NIH, is a federal government agency that's operating within the United States Department of Health and Human Services that's generally responsible for all of the country's biomedical and health-related research studies.

The grants and programs of the NIH are all specially designed to assist in the realization of its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

In addition, the National Institute on Drug Abuse (NIDA) is also meaning to solicit research grant applications that seek to work towards the discovery and development of safe and effective medications for the treatment of Substance Use Disorders (SUDs), through the creation of tactical alliances and collaborations between researchers at for profit or non-profit organizations.

  (continued...)

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on children grants and education grant money.

Additional Resources

category - Health Grants

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Medical Tropical Research Laboratory Program Infectious Disease Research Award
AFRIMS has recently announced the WRAIR Medical Tropical Research Laboratory Program(MTRLP) Infectious Disease Research Award(IDRA), a funding opportunity which solicits proposals that aim to tackle basic, preclinical and clinical research of emerging infectious diseases in Thailand and a certain region in Southeast Asia.

---

Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments
NIH has recently established a program entitled Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments.

---

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research
The National Institutes of Health has formed a partnership with the National Cancer Institute(NCI) in an effort to establish the program entitled Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research.

---